about
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding modelBoronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability.Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.Editorial: ADAMs control inflammation from afar
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
CXCR2 modulators: a patent review (2009 - 2013).
@en
type
label
CXCR2 modulators: a patent review (2009 - 2013).
@en
prefLabel
CXCR2 modulators: a patent review (2009 - 2013).
@en
P2860
P1476
CXCR2 modulators: a patent review (2009 - 2013).
@en
P2093
Michael P Dwyer
Younong Yu
P2860
P304
P356
10.1517/13543776.2014.887682
P407
P577
2014-02-20T00:00:00Z